{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:41:10Z","timestamp":1790804470207,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["III41004"],"award-info":[{"award-number":["III41004"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.imlet.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T02:55:55Z","timestamp":1539053755000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Impact of alterations in X-linked IRAK1gene and miR-146a on susceptibility and clinical manifestations in patients with systemic sclerosis"],"prefix":"10.1016","volume":"204","author":[{"given":"Misa","family":"Vreca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Andjelkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1293-6215","authenticated-orcid":false,"given":"Natasa","family":"Tosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Zekovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemanja","family":"Damjanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Spasovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2018.10.002_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1346-8138.13221","article-title":"Genetic and epigenetic abnormalities in systemic sclerosis","volume":"43","author":"Makino","year":"2016","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.imlet.2018.10.002_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.imlet.2018.10.002_bib0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/imt.13.173","article-title":"Potential use of TNF-alpha inhibitors in systemic sclerosis","volume":"6","author":"Murdaca","year":"2014","journal-title":"Immunotherapy"},{"issue":"9","key":"10.1016\/j.imlet.2018.10.002_bib0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2018.10.002_bib0025","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1136\/annrheumdis-2012-202742","article-title":"New insight on the Xq28 association with systemic sclerosis","volume":"72","author":"Carmona","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.imlet.2018.10.002_bib0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2815","article-title":"The X chromosome in immune functions: when a chromosome makes the difference","volume":"10","author":"Libert","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2018.10.002_bib0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2009.03.005","article-title":"Female predominance and X chromosome defects in autoimmune diseases","volume":"33","author":"Invernizzi","year":"2009","journal-title":"J. Autoimmun."},{"issue":"15","key":"10.1016\/j.imlet.2018.10.002_bib0040","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1073\/pnas.0901181106","article-title":"Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus","volume":"106","author":"Jacob","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2017","key":"10.1016\/j.imlet.2018.10.002_bib0045","first-page":"4915950","article-title":"TMEM187-IRAK1 polymorphisms associated with rheumatoid arthritis susceptibility in Tunisian and French female populations: influence of geographic origin","author":"Khalifa","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.imlet.2018.10.002_bib0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1097-2765(03)00053-4","article-title":"Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members","volume":"11","author":"Janssens","year":"2003","journal-title":"Mol. Cell."},{"issue":"2003","key":"10.1016\/j.imlet.2018.10.002_bib0055","article-title":"The interleukin-1 receptor\/Toll-like receptor superfamily: signal transduction during inflammation and host defense","volume":"171","author":"Dunne","year":"2003","journal-title":"Sci. STKE"},{"issue":"3","key":"10.1016\/j.imlet.2018.10.002_bib0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0167-4889(02)00320-8","article-title":"Summary and comparison of the signaling mechanisms of the Toll\/interleukin-1 receptor family","volume":"1592","author":"Martin","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.imlet.2018.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/rccm.200603-341OC","article-title":"Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis","volume":"173","author":"Arcaroli","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.imlet.2018.10.002_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00296-012-2379-3","article-title":"IRAK1 rs3027898 C\/A polymorphism is associated with risk of rheumatoid arthritis","volume":"33","author":"Zhang","year":"2013","journal-title":"Rheumatol Int."},{"issue":"1","key":"10.1016\/j.imlet.2018.10.002_bib0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.intimp.2015.07.042","article-title":"Critical roles of microRNAs in the pathogenesis of systemic sclerosis: new advances, challenges and potential directions","volume":"28","author":"Miao","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.imlet.2018.10.002_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.imlet.2018.10.002_bib0085","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1101\/gad.1184404","article-title":"Specificity of microRNA target selection in translational repression","volume":"18","author":"Doench","year":"2004","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.imlet.2018.10.002_bib0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.imlet.2018.10.002_bib0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2230.2008.02804.x","article-title":"MicroRNAs: novel regulators in skin inflammation","volume":"33","author":"Sonkoly","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.imlet.2018.10.002_bib0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.gde.2005.08.005","article-title":"How microRNAs control cell division, differentiation and death","volume":"15","author":"Miska","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"4","key":"10.1016\/j.imlet.2018.10.002_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tibs.2007.02.006","article-title":"A developmental view of microRNA function","volume":"32","author":"Zhao","year":"2007","journal-title":"Trends Biochem. Sci."},{"issue":"7","key":"10.1016\/j.imlet.2018.10.002_bib0110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.it.2008.04.004","article-title":"microRNAs and the immune response","volume":"29","author":"Lindsay","year":"2008","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2018.10.002_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semcancer.2008.01.005","article-title":"MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation","volume":"18","author":"Sonkoly","year":"2008","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.imlet.2018.10.002_bib0120","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s10753-012-9467-0","article-title":"Association of MicroRNA-146a with autoimmune diseases","volume":"35","author":"Xu","year":"2012","journal-title":"Inflammation"},{"issue":"33","key":"10.1016\/j.imlet.2018.10.002_bib0125","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S A."},{"issue":"Suppl. 1","key":"10.1016\/j.imlet.2018.10.002_bib0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00005-016-0443-5","article-title":"Significance of polymorphism and expression of miR-146a and NFkB1 genetic variants in patients with rheumatoid arthritis","volume":"64","author":"Bogunia-Kubik","year":"2016","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"issue":"9","key":"10.1016\/j.imlet.2018.10.002_bib0135","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1007\/s11033-012-1735-4","article-title":"Lack of association between miR-149 C&T polymorphism and cancer susceptibility: a meta-analysis based on 4,677 cases and 4,830 controls","volume":"39","author":"Zhang","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"20","key":"10.1016\/j.imlet.2018.10.002_bib0140","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1158\/0008-5472.CAN-08-2129","article-title":"A SNP in a let-7 microRNA complementary site in the KRAS 3\u2019 untranslated region increases non-small cell lung cancer risk","volume":"68","author":"Chin","year":"2008","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.imlet.2018.10.002_bib0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc2867","article-title":"Genetic variation in microRNA networks: the implications for cancer research","volume":"10","author":"Ryan","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"20","key":"10.1016\/j.imlet.2018.10.002_bib0150","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1073\/pnas.0802682105","article-title":"Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma","volume":"105","author":"Jazdzewski","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.imlet.2018.10.002_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020471","article-title":"Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis","volume":"6","author":"Xu","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.imlet.2018.10.002_bib0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jbspin.2010.05.013","article-title":"A polymorphism in the 3\u2019-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility","volume":"77","author":"Chatzikyriakidou","year":"2010","journal-title":"Jt. Bone Spine"},{"issue":"1","key":"10.1016\/j.imlet.2018.10.002_bib0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2011.08.021","article-title":"Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis","volume":"504","author":"Fenoglio","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.imlet.2018.10.002_bib0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10875-010-9461-y","article-title":"Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis","volume":"31","author":"Okubo","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2018.10.002_bib0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-3083.2010.02381.x","article-title":"The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility","volume":"71","author":"Chatzikyriakidou","year":"2010","journal-title":"Scand. J. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2018.10.002_bib0180","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.autrev.2011.11.004","article-title":"miRNAs and related polymorphisms in rheumatoid arthritis susceptibility","volume":"11","author":"Chatzikyriakidou","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.imlet.2018.10.002_bib0185","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.imlet.2018.10.002_bib0190","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2018.10.002_bib0195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.imlet.2018.10.002_bib0200","first-page":"527","article-title":"Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment","volume":"16","author":"Pignone","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2018.10.002_bib0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false Discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B (Methodol.)"},{"issue":"7","key":"10.1016\/j.imlet.2018.10.002_bib0210","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00393-014-1493-x","article-title":"The association between susceptibility to inflammatory arthritis and miR-146a, miR-499 and IRAK1 polymorphisms. A meta-analysis","volume":"74","author":"Song","year":"2015","journal-title":"Z. Rheumatol."},{"issue":"7","key":"10.1016\/j.imlet.2018.10.002_bib0215","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00393-016-0169-0","article-title":"Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis : a case control study and meta-analysis","volume":"76","author":"Yang","year":"2017","journal-title":"Z. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2018.10.002_bib0220","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3855\/jidc.6776","article-title":"Susceptibility of autoimmune diseases in three polymorphisms of infection-associated gene IRAK1","volume":"9","author":"Li","year":"2015","journal-title":"J Infect. Dev. Ctries"},{"issue":"4","key":"10.1016\/j.imlet.2018.10.002_bib0225","doi-asserted-by":"crossref","DOI":"10.1186\/ar2493","article-title":"Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Pauley","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.imlet.2018.10.002_bib0230","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cellsig.2009.01.005","article-title":"Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways","volume":"21","author":"Sanmiguel","year":"2009","journal-title":"Cell Signal."},{"issue":"2","key":"10.1016\/j.imlet.2018.10.002_bib0235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.imlet.2011.09.006","article-title":"Increased microRNA-146a\/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjogren\u2019s syndrome","volume":"141","author":"Zilahi","year":"2012","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.imlet.2018.10.002_bib0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2011.03.032","article-title":"Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population","volume":"122","author":"Yue","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.imlet.2018.10.002_bib0245","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/annrheumdis-2012-201627","article-title":"MicroRNA-146a and Ets-1 gene polymorphisms in ocular Behcet\u2019s disease and Vogt-Koyanagi-Harada syndrome","volume":"73","author":"Zhou","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.imlet.2018.10.002_bib0250","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.imlet.2018.10.002_bib0255","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1007\/s11033-010-0633-x","article-title":"Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population","volume":"38","author":"Yang","year":"2011","journal-title":"Mol. Biol. Rep."},{"issue":"10","key":"10.1016\/j.imlet.2018.10.002_bib0260","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1177\/0961203314534512","article-title":"Association of miR-146a polymorphisms with systemic lupus erythematosus: a meta-analysis","volume":"23","author":"Ji","year":"2014","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.imlet.2018.10.002_bib0265","doi-asserted-by":"crossref","DOI":"10.1186\/ar3013","article-title":"Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis","volume":"12","author":"Murata","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.imlet.2018.10.002_bib0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?","volume":"2","author":"Sonkoly","year":"2007","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.imlet.2018.10.002_bib0275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-011-0727-3","article-title":"Impaired miR-146a expression links subclinical inflammation and insulin resistance in type 2 diabetes","volume":"351","author":"Balasubramanyam","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.imlet.2018.10.002_bib0280","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.imlet.2018.10.002_bib0285","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/carcin\/bgn172","article-title":"A functional polymorphism in the miR-146a gene and age of familial breast\/ovarian cancer diagnosis","volume":"29","author":"Shen","year":"2008","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.imlet.2018.10.002_bib0290","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1261\/rna.5248604","article-title":"Fast and effective prediction of microRNA\/target duplexes","volume":"10","author":"Rehmsmeier","year":"2004","journal-title":"RNA"},{"issue":"6","key":"10.1016\/j.imlet.2018.10.002_bib0295","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ajpath.2013.02.016","article-title":"The c-Rel subunit of NF-kappaB regulates epidermal homeostasis and promotes skin fibrosis in mice","volume":"182","author":"Fullard","year":"2013","journal-title":"Am. J. Pathol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818302992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247818302992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:34:37Z","timestamp":1759044877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247818302992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":59,"alternative-id":["S0165247818302992"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.10.002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of alterations in X-linked IRAK1gene and miR-146a on susceptibility and clinical manifestations in patients with systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}